Influenza (“flu”) is a contagious disease that spreads yearly, usually between October and May. The flu is an infection that can cause fever, cough, body aches, and other symptoms. The flu vaccine is a preventative treatment that can keep you from getting sick with the flu. The flu vaccine can also make flu less severe if you do get it and keep you from spreading flu to your family and other people. Our clinic will be offering the domestic Japanese flu vaccine (injection).

2022-2023 JAPANESE QUADRIVALENT FLU VACCINE (INJECTION)

A/Victoria/1/2020 (H1N1)pdm09-like virus

A/Darwin/9/2021 (H3N2)-like virus

B/Austria/1359417/2021 (Victoria lineage)-like virus

B/Phuket/3073/2013 (Yamagata lineage)-like virus

WHO organizes consultations with an advisory group of experts to analyze influenza virus surveillance data generated by the WHO Global Influenza Surveillance and Response System (GISRS) and issues recommendations on the composition of the influenza vaccines for the following influenza season.

More information on the influenza vaccine can be found at the following link:
http://www.cdc.gov/vaccines/hcp/vis/vis-statements/flu.pdf

American Clinic Tokyo will test asymptomatic individuals preparing to travel abroad or return to Japan. We do not perform testing for symptomatic individuals.

Antigen Test (Lateral flow) – All-inclusive price of 15000 yen for the test, consumption tax, English certificate, and consultation. This test will be conducted via nasal swab and will take 15 minutes to process. You will be leaving with a physician-signed document in hand.

PCR Test (Real-time Reverse Transcription) – All-inclusive price of 25000 yen for the test, consumption tax, English certificate, and consultation. This test will be conducted via saliva (or nasopharyngeal swab if required). Samples received by 12:00 noon will be processed by 18:00. Samples received in the afternoon will be processed by 9:00 the following business day. You will be receiving a PDF via email as soon as the laboratory report is ready. This test can be used to shorten the quarantine period when entering Japan.

As of June 12th, Korea, Hong Kong, Taiwan, India, and Japan still require a negative COVID test for travelers.

COVID-19 Test Reservations: Please complete this form here. We will reach out to you as soon as possible to confirm the appointment. : https://docs.google.com/forms/d/e/1FAIpQLSe9GvGkKu3IxlOA-zSfBmOp8iQtYoLN3ZYEs3c9V78-hkO6qg/viewform?usp=sf_link

In an effort to prevent community transmission of respiratory illness (COVID-19), we are launching American Clinic Online services to our established patients. Consultations with physicians will be performed on VSee (a telemedicine platform used by NASA). Medicine will be sent to your home or office without physically visiting our clinic. Please register with the following link and call us using VSee for more information. If you cannot reach us, try our regular number at 03-4405-6210.

Sign up and connect with our reception desk here:

https://vsee.com/s/5e5861ed03c80

To schedule with an online physician, please complete our initial questionnaire here: 

https://docs.google.com/forms/d/e/1FAIpQLSe9TGxY-OXDkhDsQf-N2sGeqOpgxTe2ckSM41umG_wt4zZwGA/viewform?usp=sf_link

Japan National Tourism Organization (JNTO) operates a visitor hotline 24 hours a day, 365 days a year. Call for tourist information or assistance in the case of accidents and emergencies including novel coronavirus(COVID-19). Support is available in English, Chinese, Korean and Japanese.

• JAPAN VISITOR HOTLINE 050-3816-2787
• IF CALLING FROM OVERSEAS +81-50-3816-2787

Shingles is a painful rash caused by reactivation of the chickenpox virus. 99% of people over 50 years of age are living with the virus that causes shingles. One in three people will develop shingles in their lifetime.

SHINGRIX works to boost your body’s protection against shingles (herpes zoster). It is a FDA-approved 2-dose series proven to be up to 90% effective in clinical trials.

It is given as a two-dose series, two months apart.

For more information please follow this link: https://www.cdc.gov/vaccines/hcp/vis/vis-statements/shingles-recombinant.pdf

If you wish to proceed, please sign up here: https://forms.gle/ehw9ojPrQemcg7bP7